Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity
May 25, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 25, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Batisha...
Syneos Health Leaders Recognized by HBA
May 17, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 17, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced that Jennifer Sozio, SVP...
Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
May 16, 2023 08:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named Maria Fotiu,...
Syneos Health Reports First Quarter 2023 Results
May 10, 2023 07:07 ET
|
Syneos Health, Inc.
Revenue for the first quarter of $1,356.8 million increased 1.5% on a reported basis and increased 2.4% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion
May 10, 2023 06:47 ET
|
Syneos Health, Inc.
Shareholders to Receive $43.00 Per Share in Cash Represents 24% Premium to Unaffected Stock Price MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos...
Syneos Health Appoints Michael Bonello as Chief Financial Officer
May 02, 2023 06:19 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael...
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
April 13, 2023 16:31 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial...
Syneos Health Wins 2023 ViE Award
April 05, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced it has been awarded...
Syneos Health Names Jeanine O’Kane as Communications President
April 04, 2023 14:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 04, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced Jeanine O’Kane as President...
Syneos Health Launches Medical Affairs Digital Amplifier
March 27, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 27, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of Medical...